Nifty

:

25960.55

Sensex

:

85102.69

-225.90 (-0.86%)
-609.68 (-0.71%)

Login

Nifty
Sensex

:
:

25960.55
85102.69

-225.90 (-0.86%)
-609.68 (-0.71%)

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

44/99

BSE: 500288 | NSE: MOREPENLAB

Watchlist

NSE BSE

40.84

08-Dec-2025

Open
High
Low
Previous Close

42.47
42.59
40.5
42.47

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1882286
77695333.48
91.7
40.5

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,237.29
22.68
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,342.25
0.49%
1.87

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.08
8.80
8.52

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.95
7.99
16.96

PAT CAGR (%)

10 Years
5 Years
3 Years

24.88
3.98
45.04

P:E (Median)

8 Years
5 Years
3 Years

28.57
28.44
31.52

P:BV (Average)

8 Years
5 Years
3 Years

3.70
3.38
2.78

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.86
16.70
17.70

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 369.53 383.70 -3.69% 391.28 385.64 1.46% 381.94 392.60 -2.72% 403.25 394.63 2.18%
Expenses 341.60 340.63 0.28% 372.33 337.03 10.47% 351.78 336.46 4.55% 371.68 343.52 8.20%
EBITDA 27.92 43.06 -35.16% 18.95 48.61 -61.02% 30.16 56.14 -46.28% 31.58 51.12 -38.22%
EBIDTM 7.56% 11.22% 4.84% 12.60% 7.90% 14.30% 7.83% 12.95%
Other Income 4.65 4.63 0.43% 4.09 3.07 33.22% 3.14 3.99 -21.30% 4.87 3.66 33.06%
Interest 4.11 1.05 291.43% 3.81 1.04 266.35% 3.74 0.73 412.33% 1.27 2.04 -37.75%
Depreciation 10.70 3.79 182.32% 7.88 3.59 119.50% 12.25 6.69 83.11% 4.81 5.51 -12.70%
PBT 18.86 42.86 -56.00% 11.35 47.05 -75.88% 17.30 52.71 -67.18% 30.38 47.22 -35.66%
Tax 4.49 10.93 -58.92% 3.29 12.00 -72.58% 5.39 12.75 -57.73% 7.69 12.02 -36.02%
PAT 14.38 31.93 -54.96% 8.06 35.05 -77.00% 11.91 39.96 -70.20% 22.69 35.20 -35.54%
PATM 3.89% 8.32% 2.06% 9.09% 3.12% 10.18% 5.63% 8.92%
EPS 0.26 0.58 -55.17% 0.15 0.64 -76.56% 0.22 0.73 -69.86% 0.41 0.64 -35.94%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 411.58 437.73 -5.97% 425.24 455.22 -6.59% 465.85 423.07 10.11% 452.78 444.55 1.85%
Expenses 380.88 393.66 -3.25% 401.07 403.60 -0.63% 423.61 374.69 13.06% 416.64 393.99 5.75%
EBITDA 30.70 44.07 -30.34% 24.17 51.62 -53.18% 42.24 48.38 -12.69% 36.14 50.57 -28.53%
EBIDTM 7.46% 10.07% 5.68% 11.34% 9.07% 11.44% 7.98% 11.37%
Other Income 4.64 4.99 -7.01% 4.41 3.43 28.57% 4.61 4.24 8.73% 5.34 4.07 31.20%
Interest 4.18 1.18 254.24% 4.04 1.15 251.30% 4.67 0.80 483.75% 1.34 2.17 -38.25%
Depreciation 11.28 1.86 506.45% 9.03 5.73 57.59% 16.47 9.62 71.21% 4.93 8.45 -41.66%
PBT 45.69 46.02 -0.72% 15.52 48.17 -67.78% 25.71 42.20 -39.08% 35.20 44.02 -20.04%
Tax 4.65 11.17 -58.37% 4.11 12.00 -65.75% 5.40 13.46 -59.88% 8.52 12.03 -29.18%
PAT 41.04 34.85 17.76% 11.40 36.17 -68.48% 20.31 28.74 -29.33% 26.69 31.99 -16.57%
PATM 9.97% 7.96% 2.68% 7.95% 4.36% 6.79% 5.89% 7.20%
EPS 0.75 0.64 17.19% 0.20 0.71 -71.83% 0.37 0.55 -32.73% 0.49 0.63 -22.22%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,546.00 1,554.54 1,537.59 1,338.88 1,449.27 1,112.42 791.99 717.24 560.83 547.51 452.46 Net Sales Growth -0.68% 1.10% 14.84% -7.62% 30.28% 40.46% 10.42% 27.89% 2.43% 21.01% Cost Of Goods Sold 996.73 929.43 904.73 847.50 921.58 691.36 487.87 448.98 335.30 328.24 273.04 Gross Profit 549.27 625.10 632.87 491.39 527.68 421.06 304.13 268.26 225.52 219.27 179.42 GP Margin 35.53% 40.21% 41.16% 36.70% 36.41% 37.85% 38.40% 37.40% 40.21% 40.05% 39.65% Total Expenditure 1,437.39 1,401.12 1,375.77 1,261.61 1,320.13 1,000.05 727.52 652.22 500.56 487.02 388.26 Power & Fuel Cost - 40.62 34.09 23.78 18.93 13.00 12.56 13.18 11.08 9.84 7.64 % Of Sales - 2.61% 2.22% 1.78% 1.31% 1.17% 1.59% 1.84% 1.98% 1.80% 1.69% Employee Cost - 177.22 160.28 146.19 150.00 123.20 98.07 84.74 68.22 60.79 51.67 % Of Sales - 11.40% 10.42% 10.92% 10.35% 11.07% 12.38% 11.81% 12.16% 11.10% 11.42% Manufacturing Exp. - 102.33 95.50 91.66 98.96 66.82 48.90 31.27 16.21 15.05 13.33 % Of Sales - 6.58% 6.21% 6.85% 6.83% 6.01% 6.17% 4.36% 2.89% 2.75% 2.95% General & Admin Exp. - 60.29 58.56 50.41 35.93 29.69 31.93 31.21 24.35 21.53 15.34 % Of Sales - 3.88% 3.81% 3.77% 2.48% 2.67% 4.03% 4.35% 4.34% 3.93% 3.39% Selling & Distn. Exp. - 70.00 99.15 84.91 44.90 44.09 35.75 31.72 29.13 29.04 19.87 % Of Sales - 4.50% 6.45% 6.34% 3.10% 3.96% 4.51% 4.42% 5.19% 5.30% 4.39% Miscellaneous Exp. - 21.23 23.47 17.16 49.84 31.89 12.45 11.11 16.26 22.53 19.87 % Of Sales - 1.37% 1.53% 1.28% 3.44% 2.87% 1.57% 1.55% 2.90% 4.11% 1.63% EBITDA 108.61 153.42 161.82 77.27 129.14 112.37 64.47 65.02 60.27 60.49 64.20 EBITDA Margin 7.03% 9.87% 10.52% 5.77% 8.91% 10.10% 8.14% 9.07% 10.75% 11.05% 14.19% Other Income 16.75 15.72 12.57 5.76 20.03 11.77 9.42 3.67 3.54 3.72 1.17 Interest 12.93 7.10 3.51 1.98 2.43 1.79 1.97 2.07 4.29 7.47 10.41 Depreciation 35.64 24.44 21.90 18.01 21.19 28.11 34.43 38.01 33.40 33.56 34.92 PBT 77.89 137.59 148.98 63.04 125.54 94.25 37.48 28.61 26.12 23.17 20.04 Tax 20.86 36.01 38.04 16.80 24.48 0.00 5.15 0.00 0.00 0.00 -0.14 Tax Rate 26.78% 26.17% 25.53% 26.65% 19.50% 0.00% 13.74% 0.00% 0.00% 0.00% -0.90% PAT 57.04 101.58 110.94 46.24 101.06 94.25 32.33 28.61 26.12 23.17 15.78 PAT before Minority Interest 57.04 101.58 110.94 46.24 101.06 94.25 32.33 28.61 26.12 23.17 15.78 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.69% 6.53% 7.22% 3.45% 6.97% 8.47% 4.08% 3.99% 4.66% 4.23% 3.49% PAT Growth -59.87% -8.44% 139.92% -54.25% 7.23% 191.52% 13.00% 9.53% 12.73% 46.83% EPS 1.04 1.85 2.02 0.84 1.84 1.72 0.59 0.52 0.48 0.42 0.29

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,755.45 1,811.58 1,690.43 1,417.53 1,546.83 1,188.06 853.07 768.54 606.51 595.47 485.08 Net Sales Growth -0.29% 7.17% 19.25% -8.36% 30.20% 39.27% 11.00% 26.72% 1.85% 22.76% Cost Of Goods Sold 1,132.96 1,113.11 1,016.87 900.22 980.35 735.29 524.19 479.12 361.28 358.35 293.33 Gross Profit 622.49 698.47 673.56 517.31 566.47 452.77 328.87 289.42 245.23 237.12 191.76 GP Margin 35.46% 38.56% 39.85% 36.49% 36.62% 38.11% 38.55% 37.66% 40.43% 39.82% 39.53% Total Expenditure 1,622.20 1,637.51 1,531.81 1,338.00 1,410.15 1,069.54 784.55 701.02 541.78 534.09 423.52 Power & Fuel Cost - 40.62 34.09 23.78 18.93 13.00 12.56 13.18 11.08 9.84 7.64 % Of Sales - 2.24% 2.02% 1.68% 1.22% 1.09% 1.47% 1.71% 1.83% 1.65% 1.57% Employee Cost - 208.91 181.47 154.68 164.25 135.59 109.91 95.36 76.53 69.69 58.29 % Of Sales - 11.53% 10.74% 10.91% 10.62% 11.41% 12.88% 12.41% 12.62% 11.70% 12.02% Manufacturing Exp. - 102.62 95.75 91.70 98.99 67.21 48.92 31.28 16.21 22.36 13.33 % Of Sales - 5.66% 5.66% 6.47% 6.40% 5.66% 5.73% 4.07% 2.67% 3.76% 2.75% General & Admin Exp. - 67.17 66.63 55.44 42.38 34.71 36.47 36.14 28.52 18.11 18.14 % Of Sales - 3.71% 3.94% 3.91% 2.74% 2.92% 4.28% 4.70% 4.70% 3.04% 3.74% Selling & Distn. Exp. - 79.99 109.98 93.01 53.58 49.66 40.11 32.73 30.04 25.79 23.45 % Of Sales - 4.42% 6.51% 6.56% 3.46% 4.18% 4.70% 4.26% 4.95% 4.33% 4.83% Miscellaneous Exp. - 25.09 27.02 19.17 51.67 34.08 12.39 13.20 18.11 29.95 23.45 % Of Sales - 1.38% 1.60% 1.35% 3.34% 2.87% 1.45% 1.72% 2.99% 5.03% 1.93% EBITDA 133.25 174.07 158.62 79.53 136.68 118.52 68.52 67.52 64.73 61.38 61.56 EBITDA Margin 7.59% 9.61% 9.38% 5.61% 8.84% 9.98% 8.03% 8.79% 10.67% 10.31% 12.69% Other Income 19.00 18.36 13.97 6.13 20.10 12.07 9.48 3.67 3.72 3.72 1.20 Interest 14.23 8.34 3.71 1.98 2.43 1.79 1.98 2.11 4.36 7.56 10.50 Depreciation 41.71 28.98 33.47 27.93 27.64 30.28 36.91 39.90 34.32 33.90 35.20 PBT 122.12 155.11 135.42 55.76 126.70 98.51 39.11 29.18 29.77 23.63 17.06 Tax 22.68 37.09 38.80 17.08 25.02 1.42 5.53 0.34 0.00 0.00 -0.13 Tax Rate 18.57% 23.91% 28.65% 30.63% 19.75% 1.44% 14.14% 1.17% 0.00% 0.00% -1.03% PAT 99.44 118.03 96.16 38.68 101.68 97.09 33.58 28.85 29.59 23.63 12.80 PAT before Minority Interest 98.78 118.02 96.62 38.68 101.68 97.09 33.58 28.84 29.77 23.63 12.80 Minority Interest -0.66 0.01 -0.46 0.00 0.00 0.00 0.00 0.01 -0.18 0.00 0.00 PAT Margin 5.66% 6.52% 5.69% 2.73% 6.57% 8.17% 3.94% 3.75% 4.88% 3.97% 2.64% PAT Growth -24.52% 22.74% 148.60% -61.96% 4.73% 189.13% 16.40% -2.50% 25.22% 84.61% EPS 1.81 2.15 1.75 0.71 1.86 1.77 0.61 0.53 0.54 0.43 0.23

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,181.50 889.02 780.11 598.17 444.97 307.25 277.46 250.56 224.34 328.85 Share Capital 109.58 102.23 102.23 95.56 89.96 89.96 89.96 89.96 89.96 209.61 Total Reserves 1,071.92 786.80 677.89 476.36 311.26 217.29 187.50 160.60 134.38 119.24 Non-Current Liabilities 78.15 37.65 34.45 32.41 26.89 25.36 21.11 17.87 15.28 55.22 Secured Loans 5.76 3.36 0.93 1.32 0.83 0.92 1.79 2.70 0.94 42.74 Unsecured Loans 20.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 36.40 31.60 28.87 26.64 24.01 22.38 17.85 13.45 12.69 10.71 Current Liabilities 461.56 352.63 290.98 402.69 375.63 329.38 320.82 322.21 308.19 150.78 Trade Payables 338.41 267.43 213.10 217.32 192.33 158.38 157.08 164.89 116.20 107.48 Other Current Liabilities 59.51 38.66 39.79 159.63 163.93 157.39 153.61 156.05 190.70 39.14 Short Term Borrowings 46.04 23.49 23.18 16.13 15.32 11.36 8.99 0.00 0.00 0.00 Short Term Provisions 17.60 23.05 14.91 9.61 4.05 2.25 1.14 1.26 1.29 4.16 Total Liabilities 1,721.21 1,279.30 1,105.54 1,033.27 847.49 661.99 619.39 590.64 547.81 534.85 Net Block 365.87 216.54 170.82 156.11 144.02 134.84 152.59 182.10 191.29 216.36 Gross Block 648.76 477.36 512.07 479.46 516.17 641.54 777.14 890.30 922.26 914.18 Accumulated Depreciation 282.88 260.83 341.25 323.35 372.14 506.70 624.55 708.20 730.96 697.82 Non Current Assets 614.42 436.40 374.69 356.50 354.71 313.73 336.06 363.54 369.25 387.98 Capital Work in Progress 28.34 24.45 17.01 14.15 1.96 0.00 0.00 0.00 0.00 0.00 Non Current Investment 127.17 126.18 117.84 117.79 118.78 118.78 117.69 117.69 117.69 117.69 Long Term Loans & Adv. 92.81 68.99 68.74 68.17 89.67 59.83 65.49 63.47 59.41 53.92 Other Non Current Assets 0.23 0.24 0.28 0.28 0.27 0.28 0.28 0.27 0.85 0.00 Current Assets 1,106.78 842.91 730.85 676.76 492.79 348.26 283.33 227.11 178.56 146.88 Current Investments 77.81 0.00 0.00 0.00 0.00 0.00 0.02 0.22 0.00 0.00 Inventories 286.39 220.15 211.35 258.25 169.61 132.47 90.84 73.94 62.50 40.82 Sundry Debtors 293.75 316.89 255.47 221.87 155.52 121.41 121.96 110.22 83.10 80.35 Cash & Bank 46.33 50.48 55.90 45.55 66.98 38.03 31.98 5.70 6.75 3.63 Other Current Assets 402.50 16.27 4.97 5.07 100.68 56.35 38.52 37.02 26.22 22.08 Short Term Loans & Adv. 331.19 239.12 203.16 146.02 90.88 50.45 30.80 31.53 21.67 16.27 Net Current Assets 645.23 490.27 439.87 274.07 117.16 18.88 -37.49 -95.10 -129.63 -3.91 Total Assets 1,721.20 1,279.31 1,105.54 1,033.26 847.50 661.99 619.39 590.65 547.81 534.86

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,156.23 847.23 752.91 578.56 424.75 284.06 253.09 225.94 196.26 300.28 Share Capital 109.58 102.23 102.23 95.56 89.96 89.96 89.96 89.96 89.96 209.61 Total Reserves 1,046.65 745.00 650.68 456.75 291.04 194.10 163.13 135.98 106.30 90.67 Non-Current Liabilities 90.49 43.93 36.88 35.50 30.06 28.42 23.38 20.20 17.80 57.47 Secured Loans 5.76 3.36 0.93 1.32 0.83 0.92 1.83 2.95 1.38 43.41 Unsecured Loans 20.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 39.85 33.82 29.74 28.24 25.39 23.82 19.01 14.42 13.59 11.34 Current Liabilities 500.65 402.04 321.16 456.46 403.80 351.44 339.17 340.12 324.86 166.56 Trade Payables 363.30 295.03 226.88 258.12 208.85 172.30 168.15 174.88 124.88 115.33 Other Current Liabilities 71.72 58.51 54.86 169.97 174.38 165.06 160.64 163.90 198.65 47.04 Short Term Borrowings 46.04 23.49 23.18 16.13 15.32 11.36 8.99 0.00 0.00 0.00 Short Term Provisions 19.60 25.02 16.24 12.24 5.25 2.72 1.39 1.33 1.33 4.19 Total Liabilities 1,778.10 1,293.20 1,110.49 1,070.06 858.15 663.46 615.18 585.81 538.29 523.68 Net Block 488.51 307.35 266.97 251.80 224.52 216.37 236.21 264.29 271.80 296.72 Gross Block 828.38 620.63 656.24 613.25 628.32 752.55 887.76 997.60 1,026.96 1,018.43 Accumulated Depreciation 339.87 313.28 389.27 361.45 403.79 536.18 651.55 733.31 755.15 721.72 Non Current Assets 618.73 404.16 354.33 335.75 331.36 291.29 315.71 342.37 346.34 366.53 Capital Work in Progress 28.34 24.45 17.01 14.15 1.96 0.00 0.00 0.00 0.00 0.00 Non Current Investment 7.17 1.30 0.00 0.00 1.08 1.08 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 94.47 70.82 70.07 69.53 103.52 73.55 79.22 77.81 73.69 69.82 Other Non Current Assets 0.23 0.24 0.28 0.28 0.27 0.28 0.28 0.27 0.85 0.00 Current Assets 1,159.37 889.04 756.16 734.30 526.79 372.18 299.47 243.44 191.95 157.15 Current Investments 77.81 0.00 0.00 0.00 0.00 0.00 0.02 0.22 0.00 0.00 Inventories 299.96 248.59 228.89 275.85 175.33 138.48 94.20 76.89 64.66 42.14 Sundry Debtors 324.76 324.94 263.25 250.64 181.98 137.68 133.75 121.85 92.95 87.94 Cash & Bank 49.36 52.12 56.31 45.97 67.89 38.88 32.21 5.95 7.59 4.36 Other Current Assets 407.48 16.44 7.15 5.29 101.59 57.14 39.29 38.54 26.74 22.71 Short Term Loans & Adv. 335.97 246.96 200.58 156.54 91.58 51.16 31.43 32.92 22.03 16.77 Net Current Assets 658.72 487.00 435.00 277.84 122.99 20.73 -39.70 -96.68 -132.92 -9.41 Total Assets 1,778.10 1,293.20 1,110.49 1,070.05 858.15 663.47 615.18 585.81 538.29 523.68

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 29.08 77.36 -102.12 -68.87 49.31 10.86 14.58 61.25 49.24 50.01 PBT 137.59 148.98 63.04 125.54 94.25 37.48 28.61 26.12 22.55 20.04 Adjustment 31.93 22.70 18.01 13.02 29.63 34.23 38.36 37.86 40.92 45.32 Changes in Working Capital -104.37 -56.96 -166.90 -183.04 -74.56 -55.33 -52.40 -2.72 -14.23 -11.09 Cash after chg. in Working capital 65.15 114.72 -85.84 -44.47 49.31 16.38 14.58 61.25 49.24 54.27 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -36.07 -37.36 -16.27 -24.39 0.00 -5.52 0.00 0.00 0.00 0.14 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.40 Cash From Investing Activity -280.42 -83.60 -36.20 -22.64 -69.09 -12.08 -10.34 -24.28 -14.67 -27.08 Net Fixed Assets -175.29 27.27 -35.47 24.52 123.41 135.60 113.16 31.96 -8.08 -7.02 Net Investments -78.80 -8.34 -0.05 0.99 0.00 -1.07 0.20 -0.22 0.00 0.25 Others -26.33 -102.53 -0.68 -48.15 -192.50 -146.61 -123.70 -56.02 -6.59 -20.31 Cash from Financing Activity 260.47 0.28 144.20 66.41 47.46 4.65 -0.35 -37.67 -31.29 -27.89 Net Cash Inflow / Outflow 9.12 -5.96 5.88 -25.09 27.68 3.43 3.89 -0.69 3.29 -4.97 Opening Cash & Equivalents 15.30 21.26 15.38 40.47 12.79 9.36 5.47 6.16 2.87 8.60 Closing Cash & Equivalent 24.43 15.30 21.26 15.38 40.47 12.79 9.36 5.47 6.16 3.63

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 32.06 73.37 -91.17 -60.24 50.83 11.02 17.37 63.41 40.73 50.07 PBT 155.11 135.42 55.76 126.70 98.51 39.11 29.18 29.77 23.04 17.06 Adjustment 37.79 34.20 27.90 19.46 31.96 36.63 40.32 38.64 41.40 45.69 Changes in Working Capital -123.69 -58.12 -158.28 -181.47 -78.18 -58.84 -51.78 -5.00 -23.72 -8.41 Cash after chg. in Working capital 69.21 111.49 -74.62 -35.31 52.29 16.89 17.71 63.41 40.73 54.34 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -37.15 -38.12 -16.55 -24.93 -1.46 -5.88 -0.34 0.00 0.00 0.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.40 Cash From Investing Activity -321.51 -83.30 -46.51 -31.68 -70.35 -12.46 -13.05 -26.93 -13.60 -27.30 Net Fixed Assets -175.29 27.27 -35.47 24.52 123.41 135.60 113.16 31.96 -8.08 -7.02 Net Investments -78.80 -8.34 -0.05 0.99 0.00 -1.07 0.20 -0.22 0.00 0.25 Others -67.42 -102.23 -10.99 -57.19 -193.76 -146.99 -126.41 -58.67 -5.52 -20.53 Cash from Financing Activity 299.89 5.20 143.54 66.33 47.27 5.49 -0.44 -37.77 -23.72 -27.26 Net Cash Inflow / Outflow 10.44 -4.72 5.86 -25.58 27.75 4.04 3.88 -1.29 3.40 -4.49 Opening Cash & Equivalents 16.95 21.67 15.80 41.39 13.64 9.60 5.72 7.00 3.60 8.85 Closing Cash & Equivalent 27.38 16.95 21.67 15.80 41.39 13.64 9.60 5.72 7.00 4.36

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 21.56 17.39 15.26 11.97 8.92 6.83 6.17 5.57 4.99 4.65 ROA 6.77% 9.30% 4.32% 10.75% 12.49% 5.05% 4.73% 4.59% 4.28% 3.05% ROE 9.81% 13.29% 6.84% 20.77% 26.61% 11.06% 10.84% 11.00% 10.69% 7.84% ROCE 13.29% 17.71% 9.15% 23.73% 24.54% 10.82% 7.74% 9.26% 9.17% 6.60% Fixed Asset Turnover 2.76 3.11 2.70 2.91 1.92 1.12 0.86 0.62 0.60 0.51 Receivable days 71.69 67.93 65.07 47.52 45.43 56.08 59.08 62.91 54.48 50.93 Inventory Days 59.47 51.22 64.01 53.88 49.56 51.46 41.93 44.40 34.44 30.13 Payable days 118.96 96.93 92.69 81.12 92.58 79.07 88.97 104.24 84.35 83.75 Cash Conversion Cycle 12.19 22.22 36.39 20.28 2.41 28.47 12.04 3.07 4.58 -2.69 Total Debt/Equity 0.07 0.03 0.03 0.03 0.04 0.04 0.47 0.53 0.22 0.20 Interest Cover 20.37 43.45 32.83 52.75 53.71 20.05 14.82 7.08 4.10 2.50

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 21.10 16.58 14.73 11.56 8.47 6.32 5.63 5.02 4.36 4.02 ROA 7.68% 8.04% 3.55% 10.55% 12.76% 5.25% 4.80% 5.30% 4.45% 2.53% ROE 11.78% 12.08% 5.93% 21.79% 29.20% 12.50% 12.04% 14.10% 12.54% 7.35% ROCE 15.48% 16.82% 8.40% 24.86% 27.13% 12.05% 10.01% 14.05% 10.18% 6.29% Fixed Asset Turnover 2.50 2.65 2.23 2.49 1.72 1.04 0.82 0.60 0.58 0.49 Receivable days 65.45 63.50 66.16 51.04 49.10 58.07 60.70 64.63 55.44 53.22 Inventory Days 55.26 51.55 64.98 53.23 48.20 49.78 40.63 42.59 32.73 29.27 Payable days 107.94 93.67 98.32 86.93 94.60 79.06 88.85 103.38 82.97 83.88 Cash Conversion Cycle 12.78 21.38 32.82 17.35 2.71 28.78 12.48 3.85 5.20 -1.39 Total Debt/Equity 0.07 0.03 0.03 0.03 0.04 0.05 0.52 0.06 0.25 0.22 Interest Cover 19.59 37.50 29.15 53.22 56.09 20.71 14.83 7.83 4.13 2.21

Top Investors:

pinfold overseas limited

morepen laboratories limited

Annual Reports:

News Update:

Morepen Laboratories’ arm executes JV agreement with Bimedical FZE
9th Sep 2025, 09:37 AM

The proposed JV company will carry on the business of manufacturing, trading and selling of medical devices related products
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback